Will PEMF (Pulsed Electro Magnetic Field) Therapy Benefit Cancer Patients?
Cancer is among the leading causes of death around the world. Only a small number of patients experience complete remission with the current therapeutic
options, which have several side effects. As a result, new treatment strategies are desperately needed.
Pulsed electromagnetic field therapy is a painless method of delivering low-field electromagnetic stimulation. The therapy has been studied extensively since the 1950s, and modern PEMF equipment has been on the market since the 1970s. PEMF therapy entails the patient lying face up on a therapy pad connected to a piece of apparatus that produces consistent, rhythmic pulses that the doctor hardly ever feels. The pulse intensity and frequency can be changed according to the patient's diagnosis. The goal is to restore normal cellular resonance.
The development of pulsed electromagnetic field therapy for treating human cancers has been aided by numerous studies that have produced encouraging outcomes. The significant impact on the overall use of PEMF therapy on human cancer treatment has been researched and noted. Breast cancer cells, for example, were exposed to PEMFs and chemotherapy agents. Compared to chemotherapy alone, this PEMF therapy resulted in additional reductions in malignant mitochondrial activity. Cancer cells are unable to grow and spread when mitochondrial activity is decreased. Results from a study by Crocetti and colleagues on the use of PMEF to treat breast cancer show that PEMF therapy, when combined with traditional therapy, can yield better results. According to the study's findings, using PEMF therapy before radiation treatment to remove a tumor helps the cells maintain their immunity and increases the number of lymphocytes and hormone production.
The body experiences oxidative stress after surgery, but experiments on rodents show that it mitigates the damage. Following surgery, women in the breast cancer trials were observed, and those who had not received PEMF therapy showed signs of metastases; in contrast, only a few in the group had received PEMF therapy. PEMFs had no negative side effects on the patients. PEMF therapy benefits patients' health by improving their prognosis, boosting the efficiency of traditional cancer treatments like chemotherapy and radiotherapy, and lowering medication dosage. PEMF can help shorten the time it takes to recover from chemotherapy. It can lessen the local damage brought on by an intravenous chemotherapy injection, including swelling, clot formation, and
hardened veins.
PEMF is not meant to treat a particular condition; instead, it works to reduce inflammation, which leads to decreased pain, increased energy, and quicker tissue healing. The role of pulsed electromagnetic field therapy is more about enhancing the body's inherent capacities for self-healing. When applied at a low frequency, pulsed electromagnetic fields (PEMF) accelerate the body's repair mechanisms. It aids in reestablishing healthy cellular function throughout the body, strengthens and activates cells to replenish their energy, gives patients a healthy energy boost, aids in reducing inflammation and pain, improves
athletic performance, and quickens the healing process following injury. Even though additional research is needed, PEMF is therapy with scientific support for its efficacy. It selectively impairs cancerous cells while sparing healthy cells and does not appear to have any significant adverse effects.
Reference: Cancer Medicine Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology Maria Vadala`1, Julio Cesar Morales-Medina2, Annamaria Vallelunga3, Beniamino Palmieri1, Carmen Laurino1 & Tommaso Iannitti4 1Department of General Surgery and Surgical
Specialties, Surgical Clinic, University of Modena and Reggio Emilia Medical School, Modena, Italy 2Centro de Investigacio´n en Reproduccio´n
Animal, CINVESTAV- Universidad Auto´noma de Tlaxcala, Tlaxcala, Mexico
3Department of Medicine and Surgery, Centre for Neurodegenerative Diseases (CEMAND), University of Salerno, Salerno, Italy 4Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, United Kingdom
options, which have several side effects. As a result, new treatment strategies are desperately needed.
Pulsed electromagnetic field therapy is a painless method of delivering low-field electromagnetic stimulation. The therapy has been studied extensively since the 1950s, and modern PEMF equipment has been on the market since the 1970s. PEMF therapy entails the patient lying face up on a therapy pad connected to a piece of apparatus that produces consistent, rhythmic pulses that the doctor hardly ever feels. The pulse intensity and frequency can be changed according to the patient's diagnosis. The goal is to restore normal cellular resonance.
The development of pulsed electromagnetic field therapy for treating human cancers has been aided by numerous studies that have produced encouraging outcomes. The significant impact on the overall use of PEMF therapy on human cancer treatment has been researched and noted. Breast cancer cells, for example, were exposed to PEMFs and chemotherapy agents. Compared to chemotherapy alone, this PEMF therapy resulted in additional reductions in malignant mitochondrial activity. Cancer cells are unable to grow and spread when mitochondrial activity is decreased. Results from a study by Crocetti and colleagues on the use of PMEF to treat breast cancer show that PEMF therapy, when combined with traditional therapy, can yield better results. According to the study's findings, using PEMF therapy before radiation treatment to remove a tumor helps the cells maintain their immunity and increases the number of lymphocytes and hormone production.
The body experiences oxidative stress after surgery, but experiments on rodents show that it mitigates the damage. Following surgery, women in the breast cancer trials were observed, and those who had not received PEMF therapy showed signs of metastases; in contrast, only a few in the group had received PEMF therapy. PEMFs had no negative side effects on the patients. PEMF therapy benefits patients' health by improving their prognosis, boosting the efficiency of traditional cancer treatments like chemotherapy and radiotherapy, and lowering medication dosage. PEMF can help shorten the time it takes to recover from chemotherapy. It can lessen the local damage brought on by an intravenous chemotherapy injection, including swelling, clot formation, and
hardened veins.
PEMF is not meant to treat a particular condition; instead, it works to reduce inflammation, which leads to decreased pain, increased energy, and quicker tissue healing. The role of pulsed electromagnetic field therapy is more about enhancing the body's inherent capacities for self-healing. When applied at a low frequency, pulsed electromagnetic fields (PEMF) accelerate the body's repair mechanisms. It aids in reestablishing healthy cellular function throughout the body, strengthens and activates cells to replenish their energy, gives patients a healthy energy boost, aids in reducing inflammation and pain, improves
athletic performance, and quickens the healing process following injury. Even though additional research is needed, PEMF is therapy with scientific support for its efficacy. It selectively impairs cancerous cells while sparing healthy cells and does not appear to have any significant adverse effects.
Reference: Cancer Medicine Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology Maria Vadala`1, Julio Cesar Morales-Medina2, Annamaria Vallelunga3, Beniamino Palmieri1, Carmen Laurino1 & Tommaso Iannitti4 1Department of General Surgery and Surgical
Specialties, Surgical Clinic, University of Modena and Reggio Emilia Medical School, Modena, Italy 2Centro de Investigacio´n en Reproduccio´n
Animal, CINVESTAV- Universidad Auto´noma de Tlaxcala, Tlaxcala, Mexico
3Department of Medicine and Surgery, Centre for Neurodegenerative Diseases (CEMAND), University of Salerno, Salerno, Italy 4Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, United Kingdom
